JPWO2022244586A5
(cg-RX-API-DMAC10.html )
2023-07-13
EP4328309A3
(en )
2024-09-25
Lipid composition
JP2022538528A5
(cg-RX-API-DMAC10.html )
2023-06-16
JP2024099778A5
(cg-RX-API-DMAC10.html )
2024-09-03
CA2481365A1
(en )
2003-10-23
Occlusive composition comprising a poly (2-cyanoacrylate) monomer
JPWO2022130990A5
(cg-RX-API-DMAC10.html )
2023-04-17
CA2176827C
(en )
1999-04-13
Use of polyethylene oxide-containing polymeric quaternary ammonium compounds in pharmaceutical compositions
JP2020518685A5
(cg-RX-API-DMAC10.html )
2021-05-20
JPWO2021049504A5
(cg-RX-API-DMAC10.html )
2023-08-14
JP2008239416A5
(cg-RX-API-DMAC10.html )
2009-11-19
JPWO2023140036A5
(cg-RX-API-DMAC10.html )
2024-02-15
JP2023538524A5
(cg-RX-API-DMAC10.html )
2024-08-13
KR960703056A
(ko )
1996-06-19
비점착성 조성물(abherent composition)
JPWO2021187531A5
(cg-RX-API-DMAC10.html )
2024-03-07
JPWO2023089976A5
(cg-RX-API-DMAC10.html )
2023-10-24
JP2016222670A5
(cg-RX-API-DMAC10.html )
2019-11-14
JP2004059781A5
(cg-RX-API-DMAC10.html )
2005-10-13
JP2004051995A5
(cg-RX-API-DMAC10.html )
2006-08-31
JP2005533904A5
(cg-RX-API-DMAC10.html )
2006-08-17
JP2021504302A5
(cg-RX-API-DMAC10.html )
2022-01-04
ES2189808T3
(es )
2003-07-16
Composiciones de aporte terapeutico y metodos de uso de las mismas.
JPWO2022153867A5
(cg-RX-API-DMAC10.html )
2023-09-06
JP2004523632A5
(cg-RX-API-DMAC10.html )
2005-12-22
JPWO2024248050A5
(cg-RX-API-DMAC10.html )
2026-04-24
JPWO2022215652A5
(cg-RX-API-DMAC10.html )
2023-07-31